전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Information For Authors

Journal Policies

The journal follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals by the International Committee of Medical Journal Editors (ICMJE, http:// www.icmje.org) and the Good Publication Practice Guidelines for Medical Journals 3rd edition by the Korean Association of Medical Journal Editors (KAMJE, https://www.kamje.or.kr/board/view?b_name=bo_ publication&bo_id=13).

1. Authors’ responsibilities
  • - Statement of human rights
    In studies of human subjects, the procedures should be in accordance with the 1975 Declaration of Helsinki (revised in 2013) (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). A statement explicitly describing the ethical background to the studies being reported should be included in all manuscripts in the Materials and Methods section. Ethics committee or institutional review board approval should be stated.
    Patients have a right to privacy that should not be infringed upon without informed consent. Do not use patients’ names, initials, or hospital numbers, especially in illustrative materials. Identifying information should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Identifying details should be omitted if they are not essential, but patient data should not be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve in some cases, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.

  • - Statement on the welfare of animals
    All animal studies should have the relevant approval and follow the ARRIVE guidelines (https://www.nc3rs.org.uk/arrive-guidelines). When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on, the care and use of laboratory animals was followed.

  • - Conflicts of interest
    Authors are responsible for disclosing all funding sources that supported their work as well as all institutional or corporate affiliations. To prevent ambiguity, authors must explicitly state whether potential conflicts do or do not exist currently and over the past 5 years. These include but are not limited to consultant arrangements, stock or other equity ownership, stock options, patent licensing arrangements, payments for conducting or publicizing the study, and consulting relationships with investment companies. A completed conflict of interest form should be submitted during manuscript submission.

  • - Funding sources
    All sources of funding should be declared on the title page. Information on the funding source (including grant identification, if available) must also be completed. Authors must describe the role of the study sponsor(s), if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source had no such involvement, the authors should so state.

  • - Redundant publication and plagiarism
    Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s).” Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant publication),” (b) “the subjects or study populations are the same or overlapped,” (c) “the methodology is typically identical or nearly so,” and (d) “the results and interpretation have little or no variations.” When submitting a manuscript, authors should include a letter informing the Editor of any potential overlap with other already published material or material being evaluated for publication and should also state how the manuscript submitted to Ewha Med J differs substantially from this other material. If all or part of the patient population was previously reported, this should be mentioned in the Materials and Methods section, with citations of the appropriate reference(s).

  • - Authorship
    All designated authors should be qualified for authorship, and those who are qualified should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, that is from inception to the published article. Authorship credit should be based only on 1) substantial contributions to conception and design or acquisition of data or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Conditions 1, 2, and 3 must all be met. The corresponding author is primarily responsible for all issues to the editor and audience. A corresponding author should be designated when there are two or more authors. When a large, multicenter group conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors and the group name. Journals generally list in the Acknowledgments, other members of the group who were involved in the acquisition of funding, collection of data, or general supervision of the research group. Acquisition of funding, collection of data, and general supervision of the research group, by themselves, does not justify authorship. All others who contributed to the work who are not authors should be named in the Acknowledgments section. After publication, Ewha Med J does not correct authorship unless a mistake has been made by the editorial staff.

  • - Copyright
    The copyright for all published materials is owned by the Ewha Medical Research Institute. An Author Consent Form signed by all authors is required upon submission.

  • - Permission for previously published contents
    If any portion of a manuscript has been previously published, the original source must be acknowledged, and the written permission from the copyright holder to reproduce the material must be submitted.

  • - Data sharing statement
    The journal accepts the ICMJE Recommendations for the data sharing statement policy (http://icmje.org/icmje-recommendations.pdf). All manuscripts that report clinical trial results should be submitted with a data sharing statement following the ICMJE guidelines of September 1, 2018. Authors may refer to the data sharing statement of the International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trialregistration.html#two).

  • - Clinical trial registration
    A clinical trial, defined as “any research project that prospectively assigns human subjects to intervention and control groups to study the cause-and-effect relationship between a medical intervention and a health outcome,” should be registered to the primary registry prior to publication. Ewha Med J accepts registration in one of the primary registries in the WHO International Clinical Trials Portal (http://www.who.int/ictrp/en/), NIH ClinicalTrials.gov (http://www.clinicaltrials.gov/), ISRCTN Registry (www.ISRCTN.org), or the Clinical Research Information Service (CRIS), Korea CDC (https://cris.hih.go.kr/cris/index.jsp). The clinical trial registration number should be provided at the end of the Abstract.
2. Reporting guidelines for specific study designs

Authors are encouraged to consult the reporting guidelines relevant to their specific study design in order not to omit important information. A good source of reporting guidelines is the EQUATOR Network (http:// www.equator-network.org/) and the United States National Institutes of Health/ National Library of Medicine (http://www.nlm.nih.gov/services/ research_report_guide.html).

3. Other policies
  • - Open access policy
    Ewha Med J is an open access journal. Accepted peer-reviewed articles are freely available on the journal website for any user, worldwide, immediately upon publication without additional charge. Articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • - Advertising policy
    All advertisements and commercially sponsored publications are independent of editorial decisions. The journal does not endorse any product or service marked as an advertisement or promoted by a sponsor in publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
    Editorial decisions will not be influenced by current or potential sponsors and advertisers and will not be influenced by marketing decisions. Advertisers and sponsors have no control or influence over the results of searches a user may conduct on the website by keyword or search topic.

Journal Info

EMJ
October, 2021
Vol.44 No.4

pISSN 2234-3180
eISSN 2234-2591

Archives

Editorial Office

Fax
Fax +82-2-6986-6092